Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bile Acid Excretion
88%
Chylomicrons
79%
Coronary Artery Disease
79%
Thoracic Impedance
72%
Internal Thoracic
71%
Cholesterol
68%
Low-density Lipoprotein Cholesterol Level
63%
Retinyl Palmitate
62%
Heart Failure Patients
60%
Low-density Lipoprotein Cholesterol (LDL-C)
59%
Patients with Heart Failure
54%
Chylomicron Remnants
53%
Oxidized Low-density Lipoprotein (ox-LDL)
52%
Patients with Chronic Heart Failure
50%
Postprandial Lipoproteins
47%
Lipoproteins
45%
Lipoprotein Levels
45%
High-density Lipoprotein Cholesterol (HDL-C)
43%
Elderly Patients
42%
Postprandial Lipemia
41%
Bezafibrate
41%
Lipid Levels
38%
Hormone Replacement Therapy
37%
Total Cholesterol
37%
Lymphocyte Count
37%
Normolipidemic
35%
Blood Pressure
33%
Pleural Effusion
33%
Renal Function
33%
Atherosclerotic Coronary Artery Disease
33%
Postmenopausal Women
33%
Cardiogenic Pulmonary Edema
33%
Metformin
33%
Right Lung
33%
Methylphenidate
33%
Lipolytic Activity
33%
New York Heart Association Class
32%
Bile Acids
30%
Triglycerides
27%
Heart Failure
26%
Hypertension
26%
Acute Decompensated Heart Failure
25%
Cholesterol Levels
25%
Coronary Patients
25%
Kidney
25%
Survival Prediction
25%
Intolerant
25%
Dietary Fat
25%
Estrogen
25%
Left Ventricular Ejection Fraction
25%
Pharmacology, Toxicology and Pharmaceutical Science
Lipoprotein
100%
Chylomicron
96%
Congestive Heart Failure
84%
Lipid
78%
Low Density Lipoprotein Cholesterol
70%
Chylomicron Remnant
70%
Hyperlipidemia
69%
Retinol Palmitate
69%
Replacement Therapy
56%
Cholesterol
52%
Triacylglycerol
45%
Estrogen
42%
Bezafibrate
41%
High Density Lipoprotein Cholesterol
40%
Atherosclerosis
38%
Glucose
37%
Coronary Artery Disease
36%
Methylphenidate
33%
Metformin
33%
Oxidized Low Density Lipoprotein
25%
Progestin
21%
Morbidity
21%
Case-Control Study
18%
Heparin
18%
Retinol
17%
Biological Marker
16%
Pleura Effusion
16%
Dietary Fat
16%
Crohn's Disease
16%
Thyroxine
16%
Hypothyroidism
16%
Dietary Supplement
16%
Glatiramer
16%
Antidiabetic Agent
16%
Nifedipine
16%
Hypokalemia
16%
Acute Heart Failure
16%
Multiple Sclerosis
16%
Enema
16%
Hyperphosphatemia
16%
Maturity Onset Diabetes of the Young
16%
Interleukin 10
16%
Fibric Acid Derivative
16%
Obesity
16%
Hypertension
16%
Hypocalcaemia
16%
Kidney Disease
16%
Attention Deficit Disorder
15%
Creatinine
14%
Placebo
14%
Medicine and Dentistry
Bile Acid
84%
Coronary Artery Disease
75%
Pulmonary Edema
39%
Blood Pressure
37%
Apoplexy
36%
Pleura Effusion
33%
Hypertension
26%
Infarction
22%
Urinary System
21%
Congestive Heart Failure
20%
Lymphocyte
20%
Cholesterol
19%
Peripheral Vascular Disease
19%
Diseases
18%
Retinol Palmitate
18%
Arteriosclerotic Heart Disease
18%
Coronary Atherosclerosis
18%
Leukocyte
16%
Hyperlipidemia
16%
Chylomicron Remnant
16%
Chylomicron
16%
Elderly Patient
16%
Gensini Score
16%
Anticoagulation
16%
Thromboembolism
16%
Glatiramer
16%
Crohn's Disease
16%
Multiple Sclerosis
16%
Tuberculous Osteomyelitis
16%
Tuberculous Arthritis
16%
Constipation
16%
Sodium Excretion
16%
Mitral Valve
16%
Acute Decompensated Heart Failure
16%
Indapamide
16%
Carotid Artery Disease
16%
Lower Urinary Tract Symptom
16%
Right Lung
16%
Angioimmunoblastic T-Cell Lymphoma
16%
Non ST Segment Elevation Myocardial Infarction
16%
Unstable Angina Pectoris
16%
Benzodiazepine Derivative
16%
Acquired Immune Deficiency Syndrome
16%
Essential Hypertension
16%
Cannabinoid
16%
Sulfanilamide
16%
Case-Control Study
16%
Long-Term Outcome
16%
Collagenase
16%
Antidiabetic Agent
16%
